Brief: Syros Pharmaceuticals Reports Q1 Loss Per Share $0.40

Syros Pharmaceuticals

16/05/2022 13:13

May 16 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS PHARMACEUTICALS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS AND PROVIDES A CORPORATE UPDATE
    * Q1 LOSS PER SHARE $0.40
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF
MARCH 31,
2022 WERE $112.9 MILLION
    * REVENUES WERE $5.5 MILLION FOR Q1 OF 2022
    * Q1 EARNINGS PER SHARE VIEW $-0.47, REVENUE VIEW $4.9
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nBw7CmCdha 
Further company coverage:  SYRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))